- Home
- KNSA vs NAVI Comparison
KNSA vs NAVI Comparison
Compare KNSA & NAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- NAVI
- Stock Information
- Founded
- KNSA 2015
- NAVI 1973
- Country
- KNSA United Kingdom
- NAVI United States
- Employees
- KNSA N/A
- NAVI N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- NAVI Investment Bankers/Brokers/Service
- Sector
- KNSA Health Care
- NAVI Finance
- Exchange
- KNSA Nasdaq
- NAVI Nasdaq
- Market Cap
- KNSA 1.6B
- NAVI N/A
- IPO Year
- KNSA 2018
- NAVI N/A
- Fundamental
- Price
- KNSA $21.85
- NAVI $12.98
- Analyst Decision
- KNSA Strong Buy
- NAVI Hold
- Analyst Count
- KNSA 6
- NAVI 7
- Target Price
- KNSA $37.17
- NAVI $13.79
- AVG Volume (30 Days)
- KNSA 538.6K
- NAVI 742.9K
- Earning Date
- KNSA 04-22-2025
- NAVI 04-23-2025
- Dividend Yield
- KNSA N/A
- NAVI 4.94%
- EPS Growth
- KNSA N/A
- NAVI N/A
- EPS
- KNSA N/A
- NAVI 1.18
- Revenue
- KNSA $423,239,000.00
- NAVI $848,000,000.00
- Revenue This Year
- KNSA $37.21
- NAVI N/A
- Revenue Next Year
- KNSA $1.38
- NAVI $0.88
- P/E Ratio
- KNSA N/A
- NAVI $10.97
- Revenue Growth
- KNSA 56.60
- NAVI N/A
- 52 Week Low
- KNSA $16.56
- NAVI $12.35
- 52 Week High
- KNSA $28.15
- NAVI $17.56
- Technical
- Relative Strength Index (RSI)
- KNSA 48.41
- NAVI 43.35
- Support Level
- KNSA $22.62
- NAVI $12.35
- Resistance Level
- KNSA $23.42
- NAVI $13.41
- Average True Range (ATR)
- KNSA 0.70
- NAVI 0.36
- MACD
- KNSA -0.22
- NAVI -0.05
- Stochastic Oscillator
- KNSA 15.75
- NAVI 44.68
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.